158 related articles for article (PubMed ID: 37938598)
1. Prostate cancer treatment in Portugal: a nationwide analysis.
Botelho F; Lopes R; Pina F; Silva C; Pacheco-Figueiredo L; Lunet N
Sci Rep; 2023 Nov; 13(1):19362. PubMed ID: 37938598
[TBL] [Abstract][Full Text] [Related]
2. Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer.
Kishan AU; Cook RR; Ciezki JP; Ross AE; Pomerantz MM; Nguyen PL; Shaikh T; Tran PT; Sandler KA; Stock RG; Merrick GS; Demanes DJ; Spratt DE; Abu-Isa EI; Wedde TB; Lilleby W; Krauss DJ; Shaw GK; Alam R; Reddy CA; Stephenson AJ; Klein EA; Song DY; Tosoian JJ; Hegde JV; Yoo SM; Fiano R; D'Amico AV; Nickols NG; Aronson WJ; Sadeghi A; Greco S; Deville C; McNutt T; DeWeese TL; Reiter RE; Said JW; Steinberg ML; Horwitz EM; Kupelian PA; King CR
JAMA; 2018 Mar; 319(9):896-905. PubMed ID: 29509865
[TBL] [Abstract][Full Text] [Related]
3. Five-year biochemical recurrence-free and overall survival following high-dose-rate brachytherapy with additional external beam or radical prostatectomy in patients with clinically localized prostate cancer.
Boehm K; Schiffmann J; Tian Z; Lesmana H; Larcher A; Mandel P; Karakiewicz PI; Graefen M; Schwarz R; Krüll A; Tilki D
Urol Oncol; 2016 Mar; 34(3):119.e11-8. PubMed ID: 26602027
[TBL] [Abstract][Full Text] [Related]
4. The Prognosis of Radical Prostatectomy, External Beam Radiotherapy plus Brachytherapy, and External Beam Radiotherapy Alone for Patients above 70 Years with Very High-Risk Prostate Cancer: A Population-Matched Study.
Song P; Shu M; Yang L; Di X; Liu P; Liu Z; Zhou J; Dong Q
Urol Int; 2022; 106(1):11-19. PubMed ID: 34515256
[TBL] [Abstract][Full Text] [Related]
5. Erectile function following brachytherapy, external beam radiotherapy, or radical prostatectomy in prostate cancer patients.
Putora PM; Engeler D; Haile SR; Graf N; Buchauer K; Schmid HP; Plasswilm L
Strahlenther Onkol; 2016 Mar; 192(3):182-9. PubMed ID: 26713323
[TBL] [Abstract][Full Text] [Related]
6. Commentary on "secondary cancers after intensity-modulated radiotherapy, brachytherapy, and radical prostatectomy for the treatment of prostate cancer: incidence and cause-specific survival outcomes according to the initial treatment intervention." Zelefsky MJ, Pei X, Teslova T, Kuk D, Magsanoc JM, Kollmeier M, Cox B, Zhang Z. Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY.: BJU Int 2012;110:1696-701. doi: 10.1111/j.1464-410X.2012.11385.x. [Epub 2012 Aug 13].
Gottschalk A
Urol Oncol; 2014 Feb; 32(2):209. PubMed ID: 24445290
[TBL] [Abstract][Full Text] [Related]
7. Secondary cancers after intensity-modulated radiotherapy, brachytherapy and radical prostatectomy for the treatment of prostate cancer: incidence and cause-specific survival outcomes according to the initial treatment intervention.
Zelefsky MJ; Pei X; Teslova T; Kuk D; Magsanoc JM; Kollmeier M; Cox B; Zhang Z
BJU Int; 2012 Dec; 110(11):1696-701. PubMed ID: 22889401
[TBL] [Abstract][Full Text] [Related]
8. Are biochemical recurrence outcomes similar after radical prostatectomy and radiation therapy? Analysis of prostate cancer-specific mortality by nomogram-predicted risks of biochemical recurrence.
Lee BH; Kibel AS; Ciezki JP; Klein EA; Reddy CA; Yu C; Kattan MW; Stephenson AJ
Eur Urol; 2015 Feb; 67(2):204-9. PubMed ID: 25294696
[TBL] [Abstract][Full Text] [Related]
9. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review.
Moris L; Cumberbatch MG; Van den Broeck T; Gandaglia G; Fossati N; Kelly B; Pal R; Briers E; Cornford P; De Santis M; Fanti S; Gillessen S; Grummet JP; Henry AM; Lam TBL; Lardas M; Liew M; Mason MD; Omar MI; Rouvière O; Schoots IG; Tilki D; van den Bergh RCN; van Der Kwast TH; van Der Poel HG; Willemse PM; Yuan CY; Konety B; Dorff T; Jain S; Mottet N; Wiegel T
Eur Urol; 2020 May; 77(5):614-627. PubMed ID: 32146018
[TBL] [Abstract][Full Text] [Related]
10. Impact of Hospital volume on postoperative outcomes after radical prostatectomy: A 5-Year nationwide database analysis.
Ploussard G; Grabia A; Beauval JB; Mathieu R; Brureau L; Rozet F; Rouprêt M; Lequeu CE;
Eur Urol Focus; 2022 Sep; 8(5):1169-1175. PubMed ID: 34147406
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of treatment for localized prostate cancer in a single institution: comparison of radical prostatectomy and radiation therapy by propensity score matching analysis.
Hayashi N; Osaka K; Muraoka K; Hasumi H; Makiyama K; Kondo K; Nakaigawa N; Yao M; Mukai Y; Sugiura M; Takano S; Ito E; Kaizu H; Koike I; Hata M; Taguri M; Miyoshi Y; Izumi K; Kawahara T; Uemura H
World J Urol; 2020 Oct; 38(10):2477-2484. PubMed ID: 31875247
[TBL] [Abstract][Full Text] [Related]
12. Direct comparison of low-dose-rate brachytherapy versus radical prostatectomy using the surgical definition of biochemical recurrence for patients with intermediate-risk prostate cancer.
Tsumura H; Tanaka N; Oguchi T; Owari T; Nakai Y; Asakawa I; Iijima K; Kato H; Hashida I; Tabata KI; Satoh T; Ishiyama H
Radiat Oncol; 2022 Apr; 17(1):71. PubMed ID: 35410307
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Multimodal Therapies and Outcomes Among Patients With High-Risk Prostate Cancer With Adverse Clinicopathologic Features.
Kishan AU; Karnes RJ; Romero T; Wong JK; Motterle G; Tosoian JJ; Trock BJ; Klein EA; Stish BJ; Dess RT; Spratt DE; Pilar A; Reddy C; Levin-Epstein R; Wedde TB; Lilleby WA; Fiano R; Merrick GS; Stock RG; Demanes DJ; Moran BJ; Braccioforte M; Huland H; Tran PT; Martin S; Martínez-Monge R; Krauss DJ; Abu-Isa EI; Alam R; Schwen Z; Chang AJ; Pisansky TM; Choo R; Song DY; Greco S; Deville C; McNutt T; DeWeese TL; Ross AE; Ciezki JP; Boutros PC; Nickols NG; Bhat P; Shabsovich D; Juarez JE; Chong N; Kupelian PA; D'Amico AV; Rettig MB; Berlin A; Tward JD; Davis BJ; Reiter RE; Steinberg ML; Elashoff D; Horwitz EM; Tendulkar RD; Tilki D
JAMA Netw Open; 2021 Jul; 4(7):e2115312. PubMed ID: 34196715
[TBL] [Abstract][Full Text] [Related]
14. Low-dose rate brachytherapy for men with localized prostate cancer.
Peinemann F; Grouven U; Hemkens LG; Bartel C; Borchers H; Pinkawa M; Heidenreich A; Sauerland S
Cochrane Database Syst Rev; 2011 Jul; (7):CD008871. PubMed ID: 21735436
[TBL] [Abstract][Full Text] [Related]
15. A Systematic Review of the Impact of Surgeon and Hospital Caseload Volume on Oncological and Nononcological Outcomes After Radical Prostatectomy for Nonmetastatic Prostate Cancer.
Van den Broeck T; Oprea-Lager D; Moris L; Kailavasan M; Briers E; Cornford P; De Santis M; Gandaglia G; Gillessen Sommer S; Grummet JP; Grivas N; Lam TBL; Lardas M; Liew M; Mason M; O'Hanlon S; Pecanka J; Ploussard G; Rouviere O; Schoots IG; Tilki D; van den Bergh RCN; van der Poel H; Wiegel T; Willemse PP; Yuan CY; Mottet N
Eur Urol; 2021 Nov; 80(5):531-545. PubMed ID: 33962808
[TBL] [Abstract][Full Text] [Related]
16. Quantifying treatment selection bias effect on survival in comparative effectiveness research: findings from low-risk prostate cancer patients.
Miccio JA; Talcott WJ; Jairam V; Park HS; Yu JB; Leapman MS; Johnson SB; King MT; Nguyen PL; Kann BH
Prostate Cancer Prostatic Dis; 2021 Jun; 24(2):414-422. PubMed ID: 32989262
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the Oncological and Functional Outcomes of Brachytherapy and Radical Prostatectomy for Localized Prostate Cancer.
Wang F; Luan Y; Fan Y; Huang T; Zhu L; Lu S; Tao H; Sheng T; Chen D; Ding X
Medicina (Kaunas); 2022 Oct; 58(10):. PubMed ID: 36295548
[No Abstract] [Full Text] [Related]
18. Radical prostatectomy versus high-dose rate brachytherapy for prostate cancer: effects on health-related quality of life.
Jo Y; Junichi H; Tomohiro F; Yoshinari I; Masato F
BJU Int; 2005 Jul; 96(1):43-7. PubMed ID: 15963118
[TBL] [Abstract][Full Text] [Related]
19. Impact of centralization of prostate cancer services on the choice of radical treatment.
Aggarwal A; Han L; Tree A; Lewis D; Roques T; Sangar V; van der Meulen J
BJU Int; 2023 Jan; 131(1):53-62. PubMed ID: 35726400
[TBL] [Abstract][Full Text] [Related]
20. Knife or needles? A cohort analysis of outcomes after radical prostatectomy or brachytherapy for men with low- or intermediate-risk adenocarcinoma of the prostate.
Fisher CM; Troncoso P; Swanson DA; Munsell MF; Kuban DA; Lee AK; Yeh SF; Frank SJ
Brachytherapy; 2012; 11(6):429-34. PubMed ID: 22727472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
